Distinguishing epilepsy drug treatment outcomes is crucial for treating children with tuberous sclerosis complex (TSC). Here, a deep-learning framework named AE-net was proposed to analyze epilepsy drug treatment outcomes using multi-contrast MRI data. Firstly, multi-contrast image-based models were respectively generated using the EfficientNet3D-B0 networks. Then, an averaging ensemble network was created as the final model. The proposed AE-net achieved the best AUC performance of 0.800 and sub-optimal AUC performance of 0.763 in the testing cohort, better than others. And the proposed method can predict epilepsy drug treatment outcomes to help clinical radiologists formulate more targeted treatments in the future.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords